Sporadic CRC is a heterogeneous disease that arises from the gradual accumulation of genetic and epigenetic alterations, some of which can be used as molecular markers to inform medical treatment decisions (i.e., MSI, BRAF or KRAS mutations) [12]. Here, KRAS is linked to colorectal carcinoma.